
Home | GSK US
The homepage of the GSK USA website. April 09 2025 GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025 ; March 25 2025 …
Products - GSK US
In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center. Our product areas Specialty medicines
Locations | GSK US
GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG. GSK websites; GSK Global website; Locations …
Careers | GSK US
To be a successful business and deliver positive health impact at scale, we must meet patients’ needs with research that includes those impacted by the disease under study, attract and …
GSK employees | GSK US
GSK employees can access a web version of their Outlook email and calendar, LiveMeeting and Office Communicator. Access the GSK Information Workplace Access the GSK Password Portal
Search jobs | GSK US
Life at GSK. We are transforming our culture to create an environment where individuals and teams are inspired to be ambitious for patients
Contact us - GSK
Contact us online at GSK for You. RRC - a reimbursement support program that helps patients and healthcare professionals in the US with coverage, coding and reimbursement issues for …
GSK invests up to $800 million in Pennsylvania site, largest ...
Oct 24, 2024 · GSK plc (LSE/NYSE: GSK) today announced its largest U.S. manufacturing investment to date. The up to $800 million investment will bring state-of-the-art drug substance …
Sensodyne® Rapid Relief Launches in the United States - GSK
GSK Consumer Healthcare today announced the nationwide launch of Sensodyne ® Rapid Relief, a new clinically-proven toothpaste that helps beat sensitivity in as little as 3 days with …
Gepotidacin accepted for priority review by US FDA for treatment …
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for gepotidacin, an investigational, first-in-class …